Through these five grant programs, AFAR is awarding more than $2.4 million to 36 talented investigators. To date, AFAR has given more than $189 million to nearly 4,300 researchers.
AFAR’s Biology of Aging grant programs have demonstrated over the years that by studying the basic biology of aging and aging mechanisms underlying age-related diseases, we can potentially delay many common, chronic diseases, including cancer, stroke, heart disease, type 2 diabetes, and Alzheimer’s disease.
AFAR awards 35 to 40 grants and scholarships each year. These grants support research along a continuum, from very basic studies of model systems, molecules, and cells to studies that are building on early-stage translational research addressing human aging and healthspan. Learn more about Funding Opportunities available through AFAR here.
Selection Process
AFAR grantees are selected through scientifically rigorous, multiple review processes to ensure that only the most promising science and investigators receive our support. Members of AFAR’s Scientific Review Committees — more than 300 members strong — are accomplished experts in biomedical research on aging, including many former AFAR grantees. AFAR’s multiple review processes are regarded as the standard in the field. Learn more about the 2021 Committees and chairs here.
Sponsors and Collaborators
AFAR is grateful to the Glenn Foundation for Medical Research for their generous support and collaboration.
Additional major funders of the Grants for Junior Faculty include: The AFAR Board of Directors, Anonymous, The Rose Badgeley Trust, The James A. and Dorothy R. Brunn Foundation, The Irene Diamond Fund, David W. Gore, Diana Jacobs Kalman, The Marion Esser Kaufmann Foundation, Diane Nixon, and The Irving S. Wright Endowment.
Additional support for the Postdoctoral Fellowships provided by Michael Shen, MIT’13.
AFAR is grateful to Diana Jacobs Kalman, Board Chair Emerita, for her generous support.
AFAR is grateful to the Sagol Network for their generous support and collaboration.
